Inventory restock in progress — products are available to reserve by pre-order.
    Peptide South AfricaPeptide South Africa

    Peptide research, decoded.

    Educational deep-dives on protocols, bloodwork, dosing math and the Cape Town peptide community. Every post is research-cited and written for honest, GP-led practice.

    GLP-1 Medicines Before Surgery in South Africa: A Plan, Not a Blanket Stop Rule �— Clinical Research

    Clinical Research

    GLP-1 Medicines Before Surgery in South Africa: A Plan, Not a Blanket Stop Rule

    The useful question is not simply how many days to stop a medicine. It is who will agree your medication, fasting and anaesthesia plan. Here is how to prepare for that conversation—and why a warning about stomach emptying does not mean every patient should stop treatment.

    6 min readRead
    GLP-1 Abdominal Pain: When to Seek Care and How to Report Side Effects in South Africa — South African Regulation

    South African Regulation

    GLP-1 Abdominal Pain: When to Seek Care and How to Report Side Effects in South Africa

    Recognising a possible emergency, explaining what you took and reporting a suspected side effect are three different tasks. This guide separates them—and explains what the UK’s January 2026 pancreatitis warning means for a South African conversation with your prescriber.

    5 min readRead
    Peptides in South African Sport: BPC-157, TB-500 and the 2026 WADA Rules — South African Regulation

    South African Regulation

    Peptides in South African Sport: BPC-157, TB-500 and the 2026 WADA Rules

    The 2026 World Anti-Doping Code documents place several peptides used in recovery, body-composition and performance conversations into prohibited classes. They separately place markers of semaglutide and tirzepatide on the Monitoring Program. This source-led guide explains what those two lists mean for South African athletes—and what neither list says about medicine approval, clinical evidence or safety.

    9 min readRead
    GLP-1 Blood Tests for Women Aged 26–45 in South Africa: What to Discuss Before Treatment — Bloodwork

    Bloodwork

    GLP-1 Blood Tests for Women Aged 26–45 in South Africa: What to Discuss Before Treatment

    You deserve a health assessment that listens to you. There is no universal blood panel that every woman aged 26–45 must buy before GLP-1 treatment. Use this guide to discuss relevant tests, reproductive plans and follow-up with your South African prescriber.

    6 min readRead
    GLP-1 Blood Tests for Men in South Africa: Metabolic Health, Hormones and the First Appointment — Bloodwork

    Bloodwork

    GLP-1 Blood Tests for Men in South Africa: Metabolic Health, Hormones and the First Appointment

    A useful assessment is built around your health history and symptoms—not a blanket male optimisation panel. This guide helps you prepare for a prescriber appointment and a local laboratory visit.

    5 min readRead
    South Africa's 2026 Medicine Import Rule Correction: What Changed—and What Did Not — South African Regulation

    South African Regulation

    South Africa's 2026 Medicine Import Rule Correction: What Changed—and What Did Not

    A 7 August 2026 Gazette amended South Africa's medicine regulations, including ports of entry, terminology for substandard and falsified medicines, and a broad import-permit clause. Five days later, SAHPRA said the permit provision should first have gone through public comment and requested that Regulation 6 be repealed and replaced. This explainer separates the enacted text, the correction notice and the practical checks that remain relevant.

    10 min readRead
    South Africa's 2026 GLP-1 Recall: How to Verify Semaglutide and Tirzepatide — South African Regulation

    South African Regulation

    South Africa's 2026 GLP-1 Recall: How to Verify Semaglutide and Tirzepatide

    SAHPRA, the SAPC and the HPCSA have warned against continued use or dispensing of recalled iDEXIS semaglutide and tirzepatide products. This source-led guide explains the recall, the limits of compounding and Section 21 access, and the checks that matter before a medicine reaches a patient.

    9 min readRead
    Peptide Cheat Sheet South Africa: What Each Does—and What Not to Pair Blindly — Guides

    Guides

    Peptide Cheat Sheet South Africa: What Each Does—and What Not to Pair Blindly

    A practical map of the compounds circulating in peptide conversations—what human evidence supports, what remains experimental, and why a supplement list is not a universal safety protocol.

    11 min readRead
    How to Spot a Legit Peptide Supplier: A 5-Point COA Checklist — Sourcing

    Sourcing

    How to Spot a Legit Peptide Supplier: A 5-Point COA Checklist

    Save this: a polished vial proves nothing. The evidence must identify the molecule, trace the exact batch and separate chemical purity from microbiological quality.

    5 min readRead
    Retatrutide's 144-Hour Half-Life: Why You Shouldn't Judge Your Dose After One Shot — Clinical Research

    Clinical Research

    Retatrutide's 144-Hour Half-Life: Why You Shouldn't Judge Your Dose After One Shot

    Everyone focuses on the dose — 1 mg, 2 mg, 4 mg. But how long retatrutide stays in your system may matter just as much. Here's the half-life, explained.

    6 min readRead
    Why GP-Supervised Peptide Protocols Matter (and What Most SA Suppliers Don't Tell You) — Guides

    Guides

    Why GP-Supervised Peptide Protocols Matter (and What Most SA Suppliers Don't Tell You)

    Purity percentages and same-day dispatch are table stakes. The factor that actually determines whether a protocol is safe for you specifically is rarely advertised at all.

    6 min readRead
    What Are Peptides? A Complete Guide for South African Researchers — Guides

    Guides

    What Are Peptides? A Complete Guide for South African Researchers

    Before comparing specific compounds, it helps to have the fundamentals straight — what a peptide actually is, how the major categories differ, and what to look for in a supplier.

    7 min readRead
    I Bought Tirzepatide 2-3 Months Ago and Never Mixed It — Is It Still Good? — Protocols

    Protocols

    I Bought Tirzepatide 2-3 Months Ago and Never Mixed It — Is It Still Good?

    A vial sitting sealed and dry in a closet for 2-3 months is a very different situation than a punctured, reconstituted one — and the answer depends on which form of tirzepatide you actually have.

    5 min readRead
    Retatrutide vs. Tirzepatide: What the Trial Data Actually Show — Comparison Guide

    Comparison Guide

    Retatrutide vs. Tirzepatide: What the Trial Data Actually Show

    Both are Eli Lilly incretin compounds frequently compared with each other. Phase 3 retatrutide topline results now exist, but the direct TRIUMPH-5 comparison has not reported results.

    6 min readRead
    Injection-Site Rotation: Protect Your Skin and Keep Better Records — Protocols

    Protocols

    Injection-Site Rotation: Protect Your Skin and Keep Better Records

    Rotation is part of looking after injection sites. Learn what the evidence supports, when a lump needs assessment, and what to record with each dose.

    5 min readRead
    MOTS-C: The Mitochondrial Peptide Behind the Exercise-Mimetic Research — Clinical Research

    Clinical Research

    MOTS-C: The Mitochondrial Peptide Behind the Exercise-Mimetic Research

    Most peptides are encoded in nuclear DNA. MOTS-C is different — it's encoded directly in mitochondrial DNA, and that origin is exactly why researchers are paying attention.

    6 min readRead
    Peptide Vial Shelf Life: Why the 28-Day Rule Is Not Universal — Storage & handling

    Storage & handling

    Peptide Vial Shelf Life: Why the 28-Day Rule Is Not Universal

    A blanket claim that every peptide degrades 28 days after reconstitution is not supported by a universal standard. Stability and microbiological quality are product-specific questions.

    6 min readRead
    KPV and Perimenopause: The Anti-Inflammatory Peptide Worth Knowing About — Clinical Research

    Clinical Research

    KPV and Perimenopause: The Anti-Inflammatory Peptide Worth Knowing About

    Weight gain, bloating, joint aches, brain fog and fatigue during perimenopause often trace back to one overlooked driver: chronic low-grade inflammation.

    6 min readRead
    Brain Peptides Explained: What the Research Actually Shows — Clinical Research

    Clinical Research

    Brain Peptides Explained: What the Research Actually Shows

    Six neuropeptides keep coming up in brain-health discussions. Here's how to tell which ones actually reach the brain and do something once they're there.

    8 min readRead
    Peptides for Ehlers-Danlos & Hypermobility: What the Community Reports, and What the Evidence Says — Protocols

    Protocols

    Peptides for Ehlers-Danlos & Hypermobility: What the Community Reports, and What the Evidence Says

    EDS and hypermobility communities talk about peptides more than almost any other group. Here's a careful, research-cited look at why — and where the evidence actually stops.

    8 min readRead
    ARA-290 (Cibinetide) in South Africa: The Nerve-Repair Peptide, Honestly Reviewed — Clinical Research

    Clinical Research

    ARA-290 (Cibinetide) in South Africa: The Nerve-Repair Peptide, Honestly Reviewed

    ARA-290 is the peptide people reach for when nerves — not tendons — are the problem. Here's what the human trials actually show, and how sensible access looks in South Africa.

    8 min readRead
    Tirzepatide vs Semaglutide: A Research-Backed Comparison for Weight Loss — Comparison Guide

    Comparison Guide

    Tirzepatide vs Semaglutide: A Research-Backed Comparison for Weight Loss

    Tirzepatide and semaglutide are the two most-discussed GLP-1-class peptides for weight loss. Here is what the head-to-head clinical evidence actually shows — efficacy, side effects, dosing and how to decide which one fits your protocol.

    9 min readRead
    Retatrutide TRIUMPH-1: 28.3% Weight Loss at 80 Weeks in Phase 3 — Clinical Research

    Clinical Research

    Retatrutide TRIUMPH-1: 28.3% Weight Loss at 80 Weeks in Phase 3

    Eli Lilly's TRIUMPH-1 Phase 3 topline release reported an average 28.3% weight reduction at 80 weeks with retatrutide 12 mg. A selected extension subgroup averaged 30.3% at 104 weeks. Retatrutide remains investigational, and these trial doses are not a public treatment protocol.

    7 min readRead
    Peptide Protocol Tracker: A Simple Framework You Can Run in a Notebook — Tools

    Tools

    Peptide Protocol Tracker: A Simple Framework You Can Run in a Notebook

    You don't need an app. You need a repeatable structure: what you took, when, where you injected, and what changed. Here's the tracker template we use.

    5 min readRead
    Research Peptides in Cape Town: Standards, Sourcing and Legal Reality — Sourcing

    Sourcing

    Research Peptides in Cape Town: Standards, Sourcing and Legal Reality

    If a Cape Town supplier can't show you a third-party COA matched to the vial lot, walk away. Here's the full standard.

    6 min readRead
    Peptide Workshops in Cape Town: What to Expect and Why Attend — Community

    Community

    Peptide Workshops in Cape Town: What to Expect and Why Attend

    If you're new to peptides, two hours in a room with a GP and 20 other researchers will save you six months of trial and error.

    6 min readRead
    Peptide Dosage Calculator: The Reconstitution Math, Explained Once and For All — Tools

    Tools

    Peptide Dosage Calculator: The Reconstitution Math, Explained Once and For All

    Most peptide dosing errors are math errors. Here's the simple framework — with worked examples — that eliminates them.

    7 min readRead
    The Peptide Community in South Africa: Where to Plug In — Community

    Community

    The Peptide Community in South Africa: Where to Plug In

    The SA peptide community has matured fast. Here's where to plug in — and how to filter signal from noise.

    6 min readRead
    Peptide Bloodwork Markers in South Africa: The Panel You Actually Need — Bloodwork

    Bloodwork

    Peptide Bloodwork Markers in South Africa: The Panel You Actually Need

    The right panel turns a peptide protocol from a hunch into a measurable experiment. Here's what to test in South Africa — and where.

    7 min readRead
    Longevity Biohacking in Cape Town: The Local Scene in 2026 — Community

    Community

    Longevity Biohacking in Cape Town: The Local Scene in 2026

    Cape Town has quietly become one of the most active longevity biohacking communities in the Southern Hemisphere. Here's the landscape.

    7 min readRead
    How to Track Peptide Cycles Properly (Without Becoming a Spreadsheet Person) — Tools

    Tools

    How to Track Peptide Cycles Properly (Without Becoming a Spreadsheet Person)

    Cycles aren't a vibe. They're an experiment with a start, an end, and a measurable hypothesis. Here's the framework that works.

    6 min readRead
    CJC-1295 + Ipamorelin Protocol: The GH-Axis Stack, Done Properly — Protocols

    Protocols

    CJC-1295 + Ipamorelin Protocol: The GH-Axis Stack, Done Properly

    CJC-1295 + ipamorelin is the most-run GH-axis stack in the community. Here's how to structure it, what to monitor, and what to expect.

    7 min readRead
    How to Buy Peptides in Cape Town Without Getting Burned — Sourcing

    Sourcing

    How to Buy Peptides in Cape Town Without Getting Burned

    If you're about to buy your first vial, read this. The standards have moved up, and so have the scams.

    6 min readRead
    BPC-157 + TB-500 Stack Guide: The Recovery Combination, Honestly Reviewed — Protocols

    Protocols

    BPC-157 + TB-500 Stack Guide: The Recovery Combination, Honestly Reviewed

    BPC-157 and TB-500 are the recovery community's favourite combination. Here's what the evidence supports, what it doesn't, and how to run the stack.

    7 min readRead
    BPC-157 in South Africa: Legal Status, Sourcing and Honest Use — Sourcing

    Sourcing

    BPC-157 in South Africa: Legal Status, Sourcing and Honest Use

    BPC-157 isn't a registered medicine in SA. Here's the honest read on legal access, sourcing, and what to demand from a supplier.

    6 min readRead
    BPC-157 Research in Cape Town: Animal Evidence and Product Quality — Protocols

    Protocols

    BPC-157 Research in Cape Town: Animal Evidence and Product Quality

    Why BPC-157 interests repair researchers, what animal studies actually observed, and how to evaluate a lyophilised research vial without overstating the evidence.

    7 min readRead